MBAI
Check-Cap Ltd.
NASDAQ · Healthcare · Medical - Diagnostics & Research · IL
$2.26
−18.00%Year over year
Reported trailing growth
- Revenue
- —
- EBITDA
- —
- EBIT
- —
- EPS
- —
- Free cash flow
- —
- Operating cash flow
- —
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- —
- EBITDA
- +117.5%
- EBIT
- +90.9%
- Net income
- +116.5%
- EPS
- +115.3%
- Free cash flow
- +99.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025